SMITH & NEPHEW PLC |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 975.7 GBX | +1.17% |
|
+1.02% | -9.91% |
| Apr. 11 | UK Stocks Retreat as Hope for June BoE Rate Cut Dissipates | MT |
| Apr. 11 | Proxy Advisers Raise Concerns Over Smith & Nephew's Pay Hike Proposal | MT |
Presentation Operator MessageOperator (Operator)Hello, and welcome to the Smith & Nephew First...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Smith & Nephew Plc specializes in designing, manufacturing and marketing medical products and equipment. Net sales break down by activity sector as follows:
- orthopedic surgery (39.9%): primarily orthopedic implants (hips, knees and shoulders);
- sports medicine, arthroscopy and cervicofacial surgery (31.2%): surgery and damaged tissue repair products and instruments, visualization products, etc.;
- wound care (28.9%): skin grafts for major burns victims, treatments for leg ulcers, etc.
The United States accounts for 53.7% of net sales.
Calendar
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
12.05
USD
Average target price
16.41
USD
Spread / Average Target
+36.17%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -9.91% | 10.51B | |
| +12.59% | 128B | |
| -0.39% | 8.71B | |
| +13.56% | 7B | |
| +25.94% | 5.02B | |
| +6.93% | 3.39B | |
| -1.64% | 3.02B | |
| -11.96% | 2.07B | |
| -7.25% | 2.06B | |
| -25.23% | 1.73B |
- Stock Market
- Equities
- SN. Stock
- News Smith & Nephew Plc
- Transcript : Smith & Nephew plc, Q1 2022 Sales/ Trading Statement Call, Apr 28, 2022
